Cardiac Science and School Health Corp. have announced an agreement under which School Health will sell and distribute Cardiac Science's Powerheart AEDs to schools and school districts in the U.S. They also said that the Texas Association of School Boards' (TASB) Risk Management Fund has purchased 292 Powerheart G3 Automatic AEDs and will provide them to a select group of school districts in Texas.

The latest in thrombus removal devices from Possis has received FDA clearance — the new AngioJet Ultra Thrombectomy System is the next-generation, re-engineered version of the company’s AngioJet Rheolytic Thrombectomy System.

The FDA has granted 510(k) marketing clearance for Atrium Medical Corp.’s ClearWay RX, a therapeutic perfusion catheter indicated for localized delivery of therapeutic agents to the coronary and peripheral vasculature.

A low-pressure perfusion catheter that incorporates a patented microporous PTFE balloon, Clearway RX enables controlled infusion at very low pressures (2 - 4atm) for maximum local therapeutic effect at a discrete targeted location. Delivering a smaller quantity of a preferred therapeutic agent locally has been shown to help reduce systemic effects.

The first patients to receive a new, implanted heart-monitoring device underwent procedures recently at the Clinica Marbella in Panama City, Panama.

The Sleuth Implantable ECG Monitoring System from Transoma Medical is a small medical device about the size of a 50-cent coin, was placed under the skin and continuously monitors the patient's heart.

Response Biomedical Corp. has filed an FDA 510(k) submission seeking clearance to market its RAMP NT-proBNP Test for the diagnosis of congestive heart failure. The Company has also completed a European CE Declaration to market the product in Europe.

UnitedHealthcare has announced its support for the “Door to Balloon (D2B): An Alliance for Quality” campaign recently initiated by the ACC and supported by 22 partnering organizations including the American Heart Association (AHA).

Viking Systems Inc., a designer of 3D and 2D high-performance surgical visualization systems, has launched the Viking Systems ViCam Vision System for monitoring, managing and recording complex open surgical procedures for cardiology.

In a new, five-year agreement signed last week, Datascope’s InterVascular Division will become the distributor of Sorin Group’s peripheral vascular stent products worldwide, excluding the U.S. and Japan. Datascope will have an option to acquire that side of the Sorin business.

The British Standards Institute has given CE Marking to Ventracor for its VentrAssist left ventricular assist device (LVAD), allowing the company to market and sell the device throughout Europe.

Ventracor CEO Peter Crosby stated that his company will continue its drive to develop strong clinical data published in reputable scientific journals by key opinion leaders, which is essential to build market acceptance that will drive future sales.

The Washington Post reports that while people with implanted cardioverter defibrillators (ICDs) or pacemakers do reap life-saving benefits from shocks to their hearts, these individuals also face unwanted and disturbing jolts when other injury or terminal illness brings them to life’s end. The article by Rob Stein says that the implants can make the act of dying harder, forcing terminally ill patients and families to make wrenching decisions about turning them off.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now